Ingalls & Snyder LLC’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

Ingalls & Snyder LLC’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,040	Closed	-$3K	–	456
2022 Q3	$3K	Hold	21,040	–	–	﹤0.01%	434
2022 Q2	$3K	Hold	21,040	–	–	﹤0.01%	449
2022 Q1	$9K	Hold	21,040	–	–	﹤0.01%	464
2021 Q4	$18K	Sell	21,040 -9,510	-31%	-$10.4K	﹤0.01%	469
2021 Q3	$35K	Hold	30,550	–	–	﹤0.01%	456
2021 Q2	$40K	Sell	30,550 -40,000	-57%	-$53K	﹤0.01%	456
2021 Q1	$103K	Buy	+70,550	New	+$178K	﹤0.01%	426

Ingalls & Snyder LLC's LUXAW Position: Q4 2022 in Review

Ingalls & Snyder LLC sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 21,040 shares — an estimated $3K sold.

Ingalls & Snyder LLC first reported a position in LUXAW in Q1 2021 and held it in 7 quarters. The position peaked at $103K in Q1 2021. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

Ingalls & Snyder LLC reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
Ingalls & Snyder LLC sold 21,040 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $3K.
Ingalls & Snyder LLC first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q1 2021 and held it in 7 quarters.
Ingalls & Snyder LLC's Lux Health Tech Acquisition Corp. Warrants position peaked at $103K in Q1 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on Ingalls & Snyder LLC's 13F filing for Q4 2022, filed 31 Jan 2023.